-Ettore Appella Researcher Activity Profile

Research Author Detailed Information 

Ettore Appella Publication Rate By Year

Ettore Appella has published 1 paper(s) in 2005, 5 paper(s) in 2006, 15 paper(s) in 2007, 6 paper(s) in 2008, for a total of 27 research publications in total.

Ettore E Appella Author Information

LAST NAME: appella

FIRST NAME: ettore

INITIALS: E

AFFILIATION:

Papers

Ettore Appella's Publication Record

1. The alkylating carcinogen N-methyl-N'-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases. Year Published: 2005
Center for Genomic Regulation, Program on Differentiation and Cancer, Barcelona, Spain.
2. Comparison of the specificity of interaction of cellular and viral zinc-binding domains with 2-mercaptobenzamide thioesters. Year Published: 2006
Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, 30602, USA.
3. The wild-type sequence (wt) p53(25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53(264-272) peptide CD8+ T cells. Year Published: 2006
Division of Basic Research, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.
4. Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. Year Published: 2006
Department of Chemistry, University of Virginia, Charlottesville, Virginia 22904, USA.
5. Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer. Year Published: 2006
Basic Research Program, SAIC-Frederick, National Cancer Institute-Frederick, Frederick, Maryland 21702, USA. lhwang@ncifcrf.gov
6. Studying multisite binary and ternary protein interactions by global analysis of isothermal titration calorimetry data in SEDPHAT: application to adaptor protein complexes in cell signaling. Year Published: 2006
Department of Microbiology, University of Iowa, Iowa 52242, USA.
7. Pillars article: Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992. 255: 1261-1263. Year Published: 2007
8. Toward the development of multi-epitope p53 cancer vaccines: an in vitro assessment of CD8(+) T cell responses to HLA class I-restricted wild-type sequence p53 peptides. Year Published: 2007
Department of Otolaryngology, Head and Neck Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan.
9. Single MHC mutation eliminates enthalpy associated with T cell receptor binding. Year Published: 2007
Department of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
10. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases. Year Published: 2007
Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
11. Inhibition of Estradiol Receptor/Src Association and Cell Growth by an Estradiol Receptor {alpha} Tyrosine-Phosphorylated Peptide. Year Published: 2007
Department of General Pathology, II University of Naples, Via L. De Crecchio, 7, Naples 80138, Italy. ferdinando.auricchio@unina2.it.
12. Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide. Year Published: 2007
Department of General Pathology, II University of Naples, Via L. De Crecchio, 7, Naples 80138, Italy.
13. New prospects for proteomics - electron-capture (ECD) and electron-transfer dissociation (ETD) fragmentation techniques and combined fractional diagonal chromatography (COFRADIC). Year Published: 2007
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, MD, USA.
14. Topical Microbicides: A Promising Approach for Controlling the AIDS Pandemic via Retroviral Zinc Finger Inhibitors. Year Published: 2007
Preventions Sciences Program, Division of AIDS, NIAID, National Institutes of Health, Bethesda, Maryland 20892.
15. Single MHC mutation eliminates enthalpy associated with T cell receptor binding. Year Published: 2007
Department of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
16. GSK-3beta Targets Cdc25A for Ubiquitin-Mediated Proteolysis, and GSK-3beta Inactivation Correlates with Cdc25A Overproduction in Human Cancers. Year Published: 2008
Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
17. Topical microbicides: a promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitors. Year Published: 2007
Preventions Sciences Program, Division of AIDS, NIAID, National Institutes of Health, Bethesda, Maryland 20892, USA.
18. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases. Year Published: 2007
Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
19. Topical microbicides: a promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitors. Year Published: 2007
Preventions Sciences Program, Division of AIDS, NIAID, National Institutes of Health, Bethesda, Maryland 20892, USA.
20. Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide. Year Published: 2007
Department of General Pathology, II University of Naples, Via L. De Crecchio, 7, Naples 80138, Italy.
21. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Year Published: 2008
Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110, USA.
22. New prospects for proteomics--electron-capture (ECD) and electron-transfer dissociation (ETD) fragmentation techniques and combined fractional diagonal chromatography (COFRADIC). Year Published: 2007
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, MD, USA.
23. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Year Published: 2008
Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110, USA.
24. A small molecular scaffold for selective inhibition of wip1 phosphatase. Year Published: 2008
Laboratory of Cell Biology, NCI, Bethesda, MD 20892, USA.
25. New prospects for proteomics--electron-capture (ECD) and electron-transfer dissociation (ETD) fragmentation techniques and combined fractional diagonal chromatography (COFRADIC). Year Published: 2007
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, MD, USA.
26. Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine. Year Published: 2008
Cell Cycle Control and Tumorigenesis Group, Institute of Molecular and Cell Biology, Proteos 138673, Singapore.
27. Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine. Year Published: 2008
Cell Cycle Control and Tumorigenesis Group, Institute of Molecular and Cell Biology, Proteos 138673, Singapore.